Publicaciones en colaboración con investigadores/as de University of East Anglia (18)

2024

  1. Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up

    The Lancet, Vol. 404, Núm. 10457, pp. 1019-1028

2022

  1. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

    ESMO Open, Vol. 6, Núm. 2

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. Do time trade-off values fully capture attitudes that are relevant to health-related choices?

    European Journal of Health Economics, Vol. 20, Núm. 4, pp. 559-568

  2. Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease

    Hepatology, Vol. 69, Núm. 2, pp. 699-716

  3. Gaps to bridge: Misalignment between perception, reality and actions in obesity

    Diabetes, Obesity and Metabolism, Vol. 21, Núm. 8, pp. 1914-1924

2017

  1. Exploring Differences between TTO and DCE in the Valuation of Health States

    Medical Decision Making, Vol. 37, Núm. 3, pp. 273-284

  2. Proposed guidelines to evaluate scientific validity and evidence for genotype-based dietary advice

    Genes and Nutrition, Vol. 12, Núm. 1

2016

  1. Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): A randomised, double-blind, placebo-controlled phase 3 trial

    The Lancet, Vol. 387, Núm. 10023, pp. 1066-1074

  2. From representing views to representativeness of views: Illustrating a new (Q2S) approach in the context of health care priority setting in nine European countries

    Social Science and Medicine, Vol. 166, pp. 205-213

2015

  1. Comparing WTP values of different types of QALY gain elicited from the general public

    Health Economics (United Kingdom), Vol. 24, Núm. 3, pp. 280-293

  2. Price promotions on healthier compared with less healthy foods: A hierarchical regression analysis of the impact on sales and social patterning of responses to promotions in Great Britain

    American Journal of Clinical Nutrition, Vol. 101, Núm. 4, pp. 808-816

2013

  1. Socioeconomic differences in purchases of more vs. less healthy foods and beverages: Analysis of over 25,000 British households in 2010

    Social Science and Medicine, Vol. 92, pp. 22-26

2011

  1. The social value of a QALY: Raising the bar or barring the raise?

    BMC Health Services Research, Vol. 11

2010

  1. Ordering anomalies in choice experiments

    Journal of Environmental Economics and Management, Vol. 59, Núm. 3, pp. 271-285

  2. Weighting and valuing quality-adjusted life-years using stated preference methods: Preliminary results from the social value of a QALY project

    Health Technology Assessment, Vol. 14, Núm. 27

2009

  1. Trying to estimate a monetary value for the QALY

    Journal of Health Economics, Vol. 28, Núm. 3, pp. 553-562